Inactive Instrument

Highlights EXMceuticals Inc.

Equities

EXM

CA30207T1049

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

An unknown buyer acquired EXMceuticals Portugal Lda from EXMceuticals Inc. for €0.08 million.	22-04-04	CI
Global Cannabinoids Inc. cancelled the acquisition of EXMceuticals Inc..	22-01-09	CI
Exmceuticals Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-31	CI
Global Cannabinoids entered into an exclusive non-binding letter of intent to acquire EXMceuticals Inc. in a reverse merger transaction for CAD 33.6 million.	21-03-02	CI
EXMceuticals Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	21-01-27	CI
An unknown buyer signed an agreement to acquire 70% stake in Prime Ranchers Limited from EXMceuticals Inc. for $0.15 million.	20-12-28	CI
Exmceuticals Inc. Announces Receipt of COVID-19 Research Grant and Acceleration of Portuguese Activities	20-09-08	CI
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight Covid-19 Pandemic	20-08-25	CI
Exmceuticals Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-07-03	CI
EXMceuticals Inc. cancelled the acquisition of MM Ltd.	20-06-29	CI
EXMceuticals Inc. Announces Supply Agreement for THC Distillate	20-06-11	CI
Exmceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery	20-05-07	CI
Exmceuticals Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-03-02	CI
Exmceuticals Inc. Obtains the Licence for Cannabis Research and Development from INFARMED	19-12-11	CI
Exmceuticals Inc. Reports Earnings Results for the Full Year Ended June 30, 2019	19-12-05	CI
Exmceuticals Obtains Its Research and Development License for Its Teclab Facilities in Portugal	19-10-23	CI
EXMceuticals Inc. Announces Receives Permits for Its Uganda Operations	19-06-10	CI
Exmceuticals Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-05-30	CI
EXMceuticals Inc. entered into a binding heads of terms to acquire MM Ltd. for $30 million.	19-05-06	CI
EXMceuticals Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2018	19-03-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights EXMceuticals Inc.

Equities

EXM

CA30207T1049

Highlights

Filters